Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 6.98
+0.12 (1.75%)
Apr 30, 2025, 2:45 PM CST
Chemclin Diagnostics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | - | 448.66 | 342.14 | 311.63 | 224.82 | Upgrade
|
| Trading Asset Securities | - | 470 | 643 | 613 | 328.57 | Upgrade
|
| Cash & Short-Term Investments | 889.68 | 918.66 | 985.14 | 924.63 | 553.39 | Upgrade
|
| Cash Growth | -3.16% | -6.75% | 6.54% | 67.08% | -5.10% | Upgrade
|
| Accounts Receivable | - | 25.29 | 34.06 | 35.13 | 31.28 | Upgrade
|
| Other Receivables | - | 6.48 | 2.94 | 3.21 | 3.25 | Upgrade
|
| Receivables | - | 31.77 | 37.01 | 38.34 | 34.52 | Upgrade
|
| Inventory | - | 110.61 | 112.56 | 122.36 | 98.67 | Upgrade
|
| Other Current Assets | - | 41.59 | 30.55 | 5.96 | 15.75 | Upgrade
|
| Total Current Assets | - | 1,103 | 1,165 | 1,091 | 702.34 | Upgrade
|
| Property, Plant & Equipment | - | 495.01 | 223.44 | 157.85 | 125.54 | Upgrade
|
| Goodwill | - | 153.76 | 153.76 | 153.76 | 153.76 | Upgrade
|
| Other Intangible Assets | - | 34.24 | 13.97 | 13.75 | 14.07 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 22.08 | 15.17 | 10.7 | 4.02 | Upgrade
|
| Long-Term Deferred Charges | - | 12.84 | 19.59 | 3.55 | 7.1 | Upgrade
|
| Total Assets | - | 1,821 | 1,591 | 1,431 | 1,007 | Upgrade
|
| Accounts Payable | - | 90.24 | 67.75 | 22.03 | 32.04 | Upgrade
|
| Accrued Expenses | - | 22.22 | 38.88 | 24.13 | 15.26 | Upgrade
|
| Current Portion of Leases | - | 6.66 | 10.9 | 11.39 | - | Upgrade
|
| Current Income Taxes Payable | - | 9.61 | 16.48 | 9.28 | 6.5 | Upgrade
|
| Current Unearned Revenue | - | 6.91 | 4.58 | 3.57 | 5.4 | Upgrade
|
| Other Current Liabilities | - | 58.5 | 58.67 | 51.16 | 45.53 | Upgrade
|
| Total Current Liabilities | - | 194.13 | 197.25 | 121.56 | 104.73 | Upgrade
|
| Long-Term Debt | - | 196.67 | - | - | - | Upgrade
|
| Long-Term Leases | - | 31.28 | 1.57 | 13.22 | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 5 | 5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 9.68 | 11.77 | 12.46 | 9.73 | Upgrade
|
| Total Liabilities | - | 431.76 | 210.59 | 152.23 | 119.46 | Upgrade
|
| Common Stock | - | 401 | 401 | 401 | 360 | Upgrade
|
| Additional Paid-In Capital | - | 564.92 | 564.92 | 547.48 | 339.92 | Upgrade
|
| Retained Earnings | - | 422.88 | 414.65 | 330.2 | 187.44 | Upgrade
|
| Shareholders' Equity | 1,401 | 1,389 | 1,381 | 1,279 | 887.36 | Upgrade
|
| Total Liabilities & Equity | - | 1,821 | 1,591 | 1,431 | 1,007 | Upgrade
|
| Total Debt | 250.13 | 234.61 | 12.47 | 24.6 | - | Upgrade
|
| Net Cash (Debt) | 639.55 | 684.05 | 972.67 | 900.03 | 553.39 | Upgrade
|
| Net Cash Growth | -6.51% | -29.67% | 8.07% | 62.64% | -5.10% | Upgrade
|
| Net Cash Per Share | 1.61 | 1.72 | 2.42 | 2.33 | 1.56 | Upgrade
|
| Filing Date Shares Outstanding | 385.79 | 401 | 401 | 401 | 360 | Upgrade
|
| Total Common Shares Outstanding | 394.59 | 401 | 401 | 401 | 360 | Upgrade
|
| Working Capital | - | 908.49 | 968 | 969.74 | 597.61 | Upgrade
|
| Book Value Per Share | 3.55 | 3.46 | 3.44 | 3.19 | 2.46 | Upgrade
|
| Tangible Book Value | 1,203 | 1,201 | 1,213 | 1,111 | 719.54 | Upgrade
|
| Tangible Book Value Per Share | 3.05 | 2.99 | 3.02 | 2.77 | 2.00 | Upgrade
|
| Machinery | - | 391.37 | 381.13 | 383.66 | 358.7 | Upgrade
|
| Construction In Progress | - | 365.61 | 103.13 | 7.57 | 0.32 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.